Literature DB >> 18319272

Matrix mineralization as a trigger for osteocyte maturation.

Kazuharu Irie1, Sadakazu Ejiri, Yasunori Sakakura, Toru Shibui, Toshihiko Yajima.   

Abstract

The morphology of the osteocyte changes during the cell's lifetime. Shortly after becoming buried in the matrix, an osteocyte is plump with a rich rough endoplasmic reticulum and a well-developed Golgi complex. This "immature" osteocyte reduces its number of organelles to become a "mature" osteocyte when it comes to reside deeper in the bone matrix. We hypothesized that mineralization of the surrounding matrix is the trigger for osteocyte maturation. To verify this, we prevented mineralization of newly formed matrix by administration of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) and then examined the morphological changes in the osteocytes in rats. In the HEBP group, matrix mineralization was disturbed, but matrix formation was not affected. The osteocytes found in the unmineralized matrix were immature. Mature osteocytes were seen in the corresponding mineralized matrix in the control group. The immature osteocytes in the unmineralized matrix failed to show immunoreactivity with anti-sclerostin antibody, whereas mature osteocytes in the mineralized matrix showed immunoreactivity in both control and HEBP groups. These findings suggest that mineralization of the matrix surrounding the osteocyte is the trigger for cytodifferentiation from a plump immature form to a mature osteocyte. The osteocyte appears to start secreting sclerostin only after it matures in the mineralized bone matrix.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319272      PMCID: PMC2386767          DOI: 10.1369/jhc.2008.950527

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  22 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

2.  Effect of ethane-1-hydroxy-1,1-diphosphonate on ectopic bone formation induced by murine osteosarcoma-derived bone-inducing substance.

Authors:  H Nakahara; H Yoshikawa; K Takaoka; K Ono
Journal:  Bone       Date:  1986       Impact factor: 4.398

Review 3.  The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function.

Authors:  Shelly R Peyton; Cyrus M Ghajar; Chirag B Khatiwala; Andrew J Putnam
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

4.  Mechanosensation and Transduction in Osteocytes.

Authors:  Lynda F Bonewald
Journal:  Bonekey Osteovision       Date:  2006-10

5.  Distinct responses of different populations of bone cells to mechanical stress.

Authors:  Y Mikuni-Takagaki; Y Suzuki; T Kawase; S Saito
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

6.  Intrinsic mechanical properties of the extracellular matrix affect the behavior of pre-osteoblastic MC3T3-E1 cells.

Authors:  Chirag B Khatiwala; Shelly R Peyton; Andrew J Putnam
Journal:  Am J Physiol Cell Physiol       Date:  2006-01-11       Impact factor: 4.249

7.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

8.  Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.

Authors:  Makoto Hirao; Jun Hashimoto; Naomi Yamasaki; Wataru Ando; Hideki Tsuboi; Akira Myoui; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

Review 9.  Diphosphonates: history and mechanisms of action.

Authors:  H Fleisch
Journal:  Metab Bone Dis Relat Res       Date:  1981

10.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

View more
  28 in total

Review 1.  Osteocyte regulation of bone mineral: a little give and take.

Authors:  G J Atkins; D M Findlay
Journal:  Osteoporos Int       Date:  2012-08       Impact factor: 4.507

2.  Maturation of cortical bone suppresses periosteal osteoprogenitor proliferation in a paracrine manner.

Authors:  Young Jae Moon; Chi-Young Yun; Jeong-Chae Lee; Jung Ryul Kim; Byung-Hyun Park; Eui-Sic Cho
Journal:  J Mol Histol       Date:  2016-07-09       Impact factor: 2.611

3.  Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.

Authors:  Gerald J Atkins; Peter S Rowe; Hui P Lim; Katie J Welldon; Renee Ormsby; Asiri R Wijenayaka; Lesya Zelenchuk; Andreas Evdokiou; David M Findlay
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

Review 4.  The osteocyte: an endocrine cell ... and more.

Authors:  Sarah L Dallas; Matthew Prideaux; Lynda F Bonewald
Journal:  Endocr Rev       Date:  2013-04-23       Impact factor: 19.871

Review 5.  Role and mechanism of action of sclerostin in bone.

Authors:  Jesus Delgado-Calle; Amy Y Sato; Teresita Bellido
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

Review 6.  Osteocytogenesis: Roles of Physicochemical Factors, Collagen Cleavage, and Exogenous Molecules.

Authors:  Xuening Chen; Lichen Wang; Kaitao Zhao; Hongjun Wang
Journal:  Tissue Eng Part B Rev       Date:  2018-01-05       Impact factor: 6.389

Review 7.  Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown.

Authors:  Martha Blank; Natalie A Sims
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

8.  Analysis of the effect of osteon diameter on the potential relationship of osteocyte lacuna density and osteon wall thickness.

Authors:  John G Skedros; Gunnar C Clark; Scott M Sorenson; Kevin W Taylor; Shijing Qiu
Journal:  Anat Rec (Hoboken)       Date:  2011-08-01       Impact factor: 2.064

9.  TIEG1-NULL OSTEOCYTES DISPLAY DEFECTS IN THEIR MORPHOLOGY, DENSITY AND SURROUNDING BONE MATRIX.

Authors:  Oualid Haddad; John R Hawse; Malayannan Subramaniam; Thomas C Spelsberg; Sabine F Bensamoun
Journal:  J Musculoskelet Res       Date:  2009-09

Review 10.  Glucocorticoids and osteocyte autophagy.

Authors:  Wei Yao; Weiwei Dai; Jean X Jiang; Nancy E Lane
Journal:  Bone       Date:  2013-01-26       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.